The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $57.88

Today's change+1.01 +1.78%
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $57.88

Today's change+1.01 +1.78%
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.

Tenet Healthcare Corp up sharply

Tenet Healthcare Corp closed up sharply Tuesday, rallying (U.S.)$1.01 or 1.78% to (U.S.)$57.88. Over the last five days, shares have gained 12.17% and 14.23% year to date. Shares have outperformed the S&P 500 by 18.06% during the last year.

Key company metrics

  • Open(U.S.) $57.75
  • Previous close(U.S.) $56.87
  • High(U.S.) $58.08
  • Low(U.S.) $56.39
  • Bid / Ask-- / --
  • YTD % change+14.23%
  • Volume2,884,421
  • Average volume (10-day)3,140,459
  • Average volume (1-month)2,037,539
  • Average volume (3-month)1,728,186
  • 52-week range(U.S.) $41.47 to (U.S.) $63.61
  • Beta1.96
  • Trailing P/E56.74×
  • P/E 1 year forward26.05×
  • Forward PEG4.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.02
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.44%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue4,4284,4684,1794,042
Total other revenue--------
Total revenue4,4284,4684,1794,042
Gross profit3,7413,7803,5143,393
Total cost of revenue687688665649
Total operating expense4,1384,1313,9923,835
Selling / general / administrative2,1252,1182,0281,956
Research & development--------
Depreciation / amortization207240207209
Interest expense (income), net operating--------
Unusual expense (income)32696544
Other operating expenses, total1,0871,0161,027977
Operating income290337187207
Interest income (expense), net non-operating-199-196-186-190
Gain (loss) on sale of assets--------
Other--------
Income before tax91141117
Income after tax7581199
Income tax, total1660-188
Net income47619-26
Total adjustments to net income--------
Net income before extra. items466110-10
Minority interest-29-20-9-19
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items466110-10
Inc. avail. to common incl. extra. items47619-26
Diluted net income47619-26
Dilution adjustment0------
Diluted weighted average shares10110810198
Diluted EPS excluding extraordinary itemsvalue per share0.460.560.10-0.10
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.720.930.520.14